This “lessons learned” report presents a thorough documentation of the implementation process of the models of care for adolescents (aged ~10-19 years) living with HIV (ALHIV) in two HIV...
O’Keefe D, Samley K, Bunreth V, Marquardt T, Bobi SE, et al.
2023-04-01 • Bulletin of the World Health Organization
2023-04-01 • Bulletin of the World Health Organization
OBJECTIVE To determine whether a nurse-led model of care for patients with hepatitis C virus (HCV) infections can provide safe and effective diagnosis and treatment in a resource-poo...
Loarec A, Carnimeo V, Molfino L, Kizito W, Muyindike WR, et al.
2018-11-16 • AIDS
2018-11-16 • AIDS
: A multicentric, retrospective case-series analysis (facility-based) in five sites across Kenya, Malawi, Mozambique, and Uganda screened HIV-positive adults for hepatitis C virus (HCV) ...
Zhang M, O'Keefe D, Iwamoto M, Sann K, Kien A, et al.
2020-05-02 • Journal of Viral Hepatitis
2020-05-02 • Journal of Viral Hepatitis
Safe and efficacious pan-genotypic direct-acting antiviral (DAA) regimens, such as sofosbuvir and daclatasvir (SOF+DCV) facilitate simplified models of care for hepatitis C virus (HCV). ...
Kirakosyan O, Melikyan N, Falcao J, Khachatryan N, Atshemyan H, et al.
2022-06-21 • Public Health Action
2022-06-21 • Public Health Action
BACKGROUND Direct-acting antivirals (DAAs) are not widely used for patients with chronic hepatitis C virus (HCV) infection and multidrug- or rifampicin-resistant TB (MDR/RR-TB). We d...
Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MW, Calmy A
2010-07-21 • Journal of the American Medical Association (JAMA)
2010-07-21 • Journal of the American Medical Association (JAMA)
CONTEXT Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to furthe...
Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S, et al.
2009-04-27 • AIDS
2009-04-27 • AIDS
BACKGROUND In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...
Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, et al.
2006-07-01 • American Journal of Tropical Medicine and Hygiene
2006-07-01 • American Journal of Tropical Medicine and Hygiene
In April 2004, 137 children 6-59 months of age with uncomplicated Plasmodium falciparum (Pf) malaria (Caala, Central Angola) were randomized to receive either artemether-lumefantrine (Co...
Walker JG, Mafirakureva N, Iwamoto M, Campbell L, Kim CS, et al.
2020-05-31 • Liver International
2020-05-31 • Liver International
BACKGROUND & AIMS In 2016, Médecins Sans Frontières established the first general population Hepatitis C virus (HCV) screening and treatment site in Cambodia, offering free direct-ac...
Rolland E, Checchi F, Pinoges LLP, Balkan S, Guthmann JP, et al.
2006-04-01 • Tropical Medicine and International Health
2006-04-01 • Tropical Medicine and International Health
OBJECTIVE: To compare the cost-effectiveness of malaria treatment based on presumptive diagnosis with that of malaria treatment based on rapid diagnostic tests (RDTs). METHODS: We calcul...
Bastard M, Pinoges LLP, Balkan S, Szumilin E, Ferreyra C, et al.
2012-11-07 • PLOS One
2012-11-07 • PLOS One
Ensuring long-term adherence to therapy is essential for the success of HIV treatment. As access to viral load monitoring and genotyping is poor in resource-limited settings, a simple to...
Checchi F, Piola P, Kosack CS, Ardizzoni E, Klarkowski DB, et al.
2004-04-01 • Tropical Medicine and International Health
2004-04-01 • Tropical Medicine and International Health
We report below an in vivo antimalarial efficacy study conducted in 2002 in Bundi Bugyo, a district of western Uganda housing a large displaced population. We tested sulfadoxine-pyrimeth...
Spillane H, Nicholas S, Tang Zhirong, Szumilin E, Balkan S, et al.
2012-08-05 • Tropical Medicine and International Health
2012-08-05 • Tropical Medicine and International Health
OBJECTIVES To identify factors influencing mortality in an HIV programme providing care to large numbers of injecting drug users (IDUs) and patients co-infected with hepatitis C (HCV...
